The Effect of Complex Decongestive Therapy in Patients With Lymphedema
1 other identifier
interventional
20
1 country
1
Brief Summary
The aim of this study is to investigate objectively the effect of lymphatic fluid which is circulated with Complex Decongestive Therapy on fluid excretion from the body in patients with lymphedema.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedFirst Submitted
Initial submission to the registry
January 15, 2024
CompletedFirst Posted
Study publicly available on registry
January 24, 2024
CompletedJanuary 25, 2024
January 1, 2024
10 months
January 15, 2024
January 24, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
MoistureMeterD Compact Device
Tissue dielectric constant technique provides information about the emergence of lymphedema in the early stages and the change in the amount of water under the skin. A high-frequency electromagnetic wave produced by the device is directed to the skin by contacting the probe with the skin. The effective measurement depth is 2.5 mm. The device evaluates the amount of water under the tissue thought to be the beginning of lymphedema.
4 weeks
Liquid Intake-Urine Excretion Tracking
The subjects were asked to fill out a 24-hour fluid intake-urine excretion chart to evaluate the difference between fluid intake and urine excretion.
4 weeks
Secondary Outcomes (4)
Body Mass Index
4 weeks
Range of motion
4 weeks
Evaluation of edema
4 weeks
Lymphedema Quality of Life
4 weeks
Study Arms (1)
Treatment Group
EXPERIMENTALComplex DecongestivePhysiotherapy program was planned for the affected extremity of the cases. The treatment was performed 5 days a week, for 4 weeks, for a total of 20 sessions and each session was 60 minutes. The treatment included Manual Lymph Drainage, skin care, multi-layer bandaging, exercise and compression stockings.
Interventions
1. Manual Lymph Drainage: Cervical region lymph drainage and abdominal region lymph drainage (especially combined with abdominal breathing) were applied. 2. Skin Care: Moisturizing creams with a pH of 5.5 were applied to the extremities before bandaging. 3. Multilayer Bandaging: Short pull bandage application was applied in a gradient manner. 4. Exercise: Joint range of motion exercises, breathing exercises (abdominal breathing), decongestive exercises, and self-drainage techniques were taught. 5. Compression Stocking: After the decongestion phase was over, flat knit compression stockings were recommended according to the patient's extremity.
Eligibility Criteria
You may qualify if:
- Female cases
- Cases diagnosed with lower extremity unilateral/bilateral lymphedema
- Having received or not received radiotherapy and/or chemotherapy
You may not qualify if:
- Having received treatment for lymphedema in the last year
- Having metastatic disease
- Those diagnosed with severe heart failure and/or arrhythmia
- Arterial disorders
- Kidney diseases
- Infection in affected extremities
- Psychological disorders
- Diabetes
- Nephrotic syndrome
- Diuretic use
- Patients using chemotherapy and drugs that have toxic effects on the kidneys
- Those with liver cirrhosis, liver disease
- Neurological diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Medipol University
Istanbul, Beykoz, 34100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cemile Uydur, MsC
Avrupa Şafak Hospital Physical Therapy and Rehabilitation Unit
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 15, 2024
First Posted
January 24, 2024
Study Start
September 1, 2018
Primary Completion
June 30, 2019
Study Completion
June 30, 2019
Last Updated
January 25, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share